drugset / Trial / NCT03585530
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus
NaSingle-groupOpen-labelTreatment
Summary
Concurrent chemoradiotherapy is one of the curative options for esophageal squamous cell carcinoma. We evaluated the efficacy and toxicity of raltitrexed with concurrent radiotherapy in elderly patients with esophageal cancer.
Timeline
- Start
- 2018-09-05
- Primary completion
- 2022-01-30
- Completion
- 2022-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Raltitrexed | Small molecule | 2.6 mg/m2 | — |